Media

Select Media

  • Some Psychiatrists Have Started Prescribing Ozempic

    Dani Blum of the New York Times interviews Metabolic Psychiatry expert, Dr. Shebani Sethi, on the importance of careful prescribing of weight loss drugs to counteract weight gain side effects from antidepressants and antipsychotics.

  • The effect of Ozempic use on mental health

    Dr. Shebani Sethi provides expert commentary for Good Morning America’s news segment on the thoughtful prescribing of Ozempic and related medications to address weight gain after psychiatric care.

    Read article

  • The Hill: If Americans were healthier, we could have been better prepared for this pandemic

    Dr. Sethi writes about how nutrition contributes to overall health.

  • Forbes: Anxiety From The Covid-19 Pandemic Could Be Making Eating Disorders Worse

    Dr. Sethi discusses how the practice of medicine has changed in the age of telehealth

  • SF Chronicle: Doctors said my son’s bipolar disorder couldn’t be healed by diet. They were wrong

    San Francisco Times comments on a Metabolic Psychiatry® study in bipolar disorder led by Dr. Sethi.

  • Stanford Medicine News Center: 5 Questions: Shebani Sethi on the connection between metabolism and mental health

    Dr. Sethi answers popular questions about metabolism and mental health

  • Metabolic Mind: Metabolic Psychiatry: Metabolism & Mental Health

    Dr. Sethi defines Metabolic Psychiatry®

  • Keto & Intermittent Fasting: From Science to Clinical Applications

    Interviewed by Silvia Segerstrale at Stanford Concierge Medicine, both Dr. Shebani Sethi , and Dr. Lucia Aronica discuss ketogenic diets and intermittent fasting.

  • How Does Ultra-Processed Food Affect Our Mental Health?

    Dr. Shebani Sethi, is an interviewed guest on the top 10 health apple podcast The Doctor’s Farmacy about how ultra-processed foods affects mental health and on metabolic psychiatry - which focuses on treatment of metabolic dysfunction and investigates the influences of nutrition, inflammation, and insulin resistance on psychiatric outcomes.

  • Reevaluate your nutrition strategy amid COVID-19, doctors say

    Anika Sinha writes about the link between nutrition, blood sugar, and immunity during COVID-19 in the Stanford Daily. She interviews both a Stanford infectious disease expert and the director of metabolic psychiatry at Stanford to explain the link to mental health.

  • Insulin resistance doubles risk of major depressive disorder, Stanford study finds

    Stanford Medicine scientists have linked insulin resistance to an increased risk of developing major depressive disorder, study lead author Dr. Katie Watson indicates. About 1 in 3 American adults has insulin resistance, a silent time bomb that doubles their risk for serious depression, per Dr. Natalie Rasgon.

Learn more about Metabolic Psychiatry